July 17, 2024 Amsterdam, the Netherlands, and Cincinnati, Ohio – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and Bon Secours Mercy Health (BSMH), one of the nation's largest Catholic health systems, today announced a multi-year strategic collaboration for patient monitoring. Putting BSMH clinicians in control, the collaboration will reduce the digital burden on staff and give them more time to spend with patients. "This collaboration is part of our commitment to drive improved ...

The partnership provides access to the latest Philips monitoring innovations, including a scalable patient monitoring platform that integrates patient data and provides vital insights. It will standardize patient monitoring for BSMH's 49 hospitals, reducing costs through a predictable payment model and enabling further reinvestment in innovation. "This collaboration is part of our commitment to drive improved healthcare quality while reducing costs and addressing healthcare issues facing entire communities, ...

The SENSE XL Torso coils, designed for 1.5T and 3.0T MR scanners, are 16-element, receive-only coils used for imaging the torso and abdomen. Each coil includes a back part, a front part, and a connection box, and they operate independently without combining with other coils. These coils help produce diagnostic images that can be interpreted by trained physicians. Significance of the Recall In November, Philips recalled certain MRI scanners due to the risk of explosion, despite only one reported incident in ...

Core Points - Royal Philips has completed the cancellation of 4,437,164 shares as part of a EUR 1.5 billion share repurchase program aimed at capital reduction, which was announced on July 26, 2021 [1] - The current issued share capital of Philips amounts to EUR 187,987,876.80, representing 939,939,384 common shares [2] - Philips generated sales of EUR 18.2 billion in 2023 and employs approximately 69,100 employees, with operations in over 100 countries [3]

More information is available here. Dorin Danu Philips Investor Relations Tel.: +31 20 59 77055 E-mail: dorin.danu@philips.com Forward-looking statements Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021. Ben Zwirs Philips External Relations Tel ...

Philips expects 2024 comparable sales growth for the underlined segment in the band of 3-5%. The consensus mark for 2024 earnings is pegged at $1.54 per share, indicating an increase of 14.1% year over year. The figure has moved upward by 0.7% in the past 30 days. Zacks Rank & Stocks to Consider Some better-ranked stocks in the broader medical market sector are DaVita (DVA) , ICON (ICLR) and Encompass Health (EHC) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zac ...

June 18, 2024 Healthcare leaders indicate automation is crucial in addressing staff shortages, but staff remain skeptical Interest in Generative AI grows, with majority of health leaders investing in, or planning to invest in AI technologies to help reduce delays in patient care Amsterdam, the Netherlands– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its Future Health Index 2024 report: Better care for more people. Launched at HLTH Europe, the ni ...

Core Insights - The Future Health Index 2024 report by Royal Philips highlights the increasing reliance on virtual care and AI innovations to tackle workforce shortages, financial pressures, and rising demand in healthcare [1][2]. Group 1: Workforce Challenges - Approximately 66% of healthcare leaders report heightened levels of burnout, stress, and mental health issues among staff, with 77% indicating that staff shortages lead to delays in patient care [3][5]. - 60% of leaders express concerns about increasing waiting lists for appointments, while 57% report longer waiting times for treatments [3]. Group 2: Technology Adoption - A significant 92% of healthcare leaders believe that automating repetitive tasks is essential for alleviating staff shortages, although 65% of healthcare professionals remain skeptical about automation's effectiveness [5]. - Virtual care is recognized by 89% of leaders as positively impacting staffing shortages, with 54% noting it allows for more flexible work schedules [6]. Group 3: AI and Innovation - The report indicates that 43% of healthcare leaders are already utilizing AI for clinical decision support in patient monitoring, with 85% planning to invest in generative AI technologies [8]. - The majority of leaders are focused on integrating AI to enhance patient care and reduce wait times, emphasizing the importance of staff engagement in the adoption process [2][4]. Group 4: Financial Sustainability - 81% of healthcare leaders acknowledge that financial challenges directly affect patient care, with 59% unable to invest in advanced medical technologies [9]. - Despite financial constraints, 89% of leaders are developing growth strategies to serve more patients, while 86% prioritize reducing the environmental impact of healthcare [10]. Group 5: Research Basis - The findings of the Future Health Index 2024 report are based on proprietary research conducted among 3,000 healthcare leaders across 14 countries [11].

Core Insights - Royal Philips has launched the Zenition 90 Motorized mobile C-arm system aimed at enhancing clinical productivity and care quality for a variety of medical procedures [6][10] - The system features automated workflows and intuitive controls, allowing clinicians to manage C-arm movements effectively, which is expected to save time during procedures [3][10] Company Overview - Royal Philips is a global leader in health technology, focusing on improving health and well-being through innovation, with 2023 sales of EUR 18.2 billion and approximately 69,100 employees [13] - The company operates in over 100 countries, providing solutions in diagnostic imaging, ultrasound, image-guided therapy, and personal health [13] Product Features - The Zenition 90 Motorized offers high power (25 kW) for superior image quality and is designed to meet complex vascular and clinical needs [10][11] - Usability studies indicate that 100% of clinicians felt in control of C-arm movements, and 97% believe that workflow features will enhance efficiency [3][4] Sustainability Commitment - Philips has improved the product life of the Zenition 90 Motorized by 25% and enhanced power efficiency by 13% as part of its EcoDesign process [11]

June 17, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized, designed to help clinicians deliver high-quality care to more patients. Philips is partnering with its customers to improve productivity. The new mobile C-arm with expanded capabilities is designed to meet complex vascular needs, but also a range of clinical procedures such as cardia ...